XML 42 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes (Details 1) - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 23,936,000 $ 22,996,000
Orphan drug and research and development credit carry forwards 8,315,000 8,333,000
Equity based compensation 1,331,000 1,331,000
Intangibles 1,051,000 1,164,000
Total 34,633,000 33,824,000
Valuation allowance (34,633,000) (33,824,000)
Net deferred tax assets